THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA rule may aid drug firms in liability suits

Curbs to preempt state requirements on label warnings

By Diedtra Henderson
Globe Staff / January 19, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A new rule issued by the Food and Drug Administration yesterday to make cryptic drug labels easier to read also preempts state laws that conflict with the agency's stance on drug warnings, aiding manufacturers in some liability lawsuits. (Full article: 659 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass